ASC
AGN

Atalanta Sosnoff Capital’s Allergan plc AGN Stock Holding History

Atalanta Sosnoff Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-107,988
Closed -$25.8M – 101
2017
Q1 		$25.8M Buy
+107,988
New +$25.1M 0.91% 52
2016
Q4 		– Sell
-168,108
Closed -$38.7M – 114
2016
Q3 		$38.7M Buy
168,108
+16,266
+11% +$3.97M 1.34% 34
2016
Q2 		$35.1M Sell
151,842
-78,267
-34% -$18M 1.17% 34
2016
Q1 		$61.7M Buy
230,109
+20,885
+10% +$5.98M 1.94% 14
2015
Q4 		$65.4M Sell
209,224
-129,853
-38% -$38.7M 1.95% 19
2015
Q3 		$92.2M Sell
339,077
-139,972
-29% -$43M 2.94% 9
2015
Q2 		$145M Buy
479,049
+48,422
+11% +$14.4M 3.98% 2
2015
Q1 		$128M Buy
430,627
+161,446
+60% +$46M 3.41% 4
2014
Q4 		$69.3M Buy
+269,181
New +$67.3M 1.71% 25

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Atalanta Sosnoff Capital's AGN Position: Q2 2017 in Review

Atalanta Sosnoff Capital sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 107,988 shares — an estimated $25.8M sold.

Atalanta Sosnoff Capital first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $145M in Q2 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Atalanta Sosnoff Capital reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Atalanta Sosnoff Capital sold 107,988 Allergan plc shares in Q2 2017, an estimated $25.8M.
  • Atalanta Sosnoff Capital first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
  • Atalanta Sosnoff Capital's Allergan plc position peaked at $145M in Q2 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Atalanta Sosnoff Capital's 13F filing for Q2 2017, filed 19 Jul 2017.